11.7
CiteScore
7.9
Impact Factor
Turn off MathJax
Article Contents

Protein palmitoylation in disease: decoding its crosstalk with ubiquitination and phosphorylation for pathogenic mechanisms and targeted therapeutics

doi: 10.1016/j.jgg.2026.10.014
Funds:

This work was supported by grants from the Natural Science Foundation of Henan Province (261111521000 to Yinming Liang), the science and technology innovation Program of Hunan Province (2024RC1071 to Yinming Liang), and the Research Start-up Funding of Henan Medical University (505483 to Binhui Zhou and 505529 to Liu Cao). All mechanistic diagrams in this review were created using FigDraw (www.figdraw.com).

  • Received Date: 2026-07-16
  • Accepted Date: 2026-10-22
  • Rev Recd Date: 2026-10-21
  • Available Online: 2026-10-27
  • Protein S-palmitoylation is a reversible lipid modification that governs protein stability, trafficking, and signaling. Rather than an isolated tag, it acts as a spatiotemporal routing signal within an integrated post-translational modification (PTM) network, engaging in three defined crosstalk modes with ubiquitination and phosphorylation: synergistic, antagonistic, and cascading. Although crosstalk with acetylation and myristoylation exists, this review focuses on the ubiquitination- and phosphorylation-centered networks most directly linked to palmitoylation in disease. The same palmitoylation event can stabilize or destabilize substrates, or activate or silence signaling, depending on the specific Zinc finger DHHC domain-containing protein (ZDHHC) isoform, subcellular location, local enzyme availability, and metabolic state. We further introduce the “PTM context signature”, a four-variable predictive framework for disease-specific crosstalk outcomes. By dissecting palmitoylation-centered crosstalk through a disease-oriented lens, we examine how its dysregulation drives oncogenesis, inflammation, metabolic disorders, and neurodegeneration. We then translate these mechanistic principles into a network-centric therapeutic framework, evaluating ZDHHC-directed modulators, peptide-based interface disruptors, and crosstalk-informed combinations that target context-specific nodes and anticipate therapy resistance. Viewing palmitoylation as an integrated component of the cellular PTM network, rather than as an isolated lipid tag, provides a framework for understanding disease pathogenesis and for targeting PTM networks rather than single modifications.
  • loading
  • Abrami, L., Kunz, B., Iacovache, I., van der Goot, F.G., 2008. Palmitoylation and ubiquitination regulate exit of the Wnt signaling protein LRP6 from the endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 105, 5384-5389.
    Abrami, L., Leppla, S.H., van der Goot, F.G., 2006. Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis. J. Cell Biol. 172, 309-320.
    Afrin, S., El Sabeh, M., Islam, M.S., Miyashita-Ishiwata, M., Malik, M., Catherino, W.H., Akimzhanov, A.M., Boehning, D., Yang, Q., Al-Hendy, A., et al., 2021. Simvastatin modulates estrogen signaling in uterine leiomyoma via regulating receptor palmitoylation, trafficking and degradation. Pharmacol. Res. 172, 105856.
    Ali, A., Levantini, E., Teo, J.T., Goggi, J., Clohessy, J.G., Wu, C.S., Chen, L., Yang, H., Krishnan, I., Kocher, O., et al., 2018. Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer. EMBO Mol. Med. 10, e8313.
    Anam, Z., Kumari, G., Mukherjee, S., Rex, D.A.B., Biswas, S., Maurya, P., Ravikumar, S., Gupta, N., Kushawaha, A.K., Sah, R.K., et al., 2022. Complementary crosstalk between palmitoylation and phosphorylation events in MTIP regulates its role during Plasmodium falciparum invasion. Front. Cell. Infect. Microbiol. 12, 924424.
    Anania, V.G., Coscoy, L., 2011. Palmitoylation of MIR2 is required for its function. J. Virol. 85, 2288-2295.
    Bai, X., Guo, Y.R., Zhang, W.C., Shi, Z.H., Dai, D.Q., 2026. Targeting the ZDHHC9-mediated STAT1 palmitoylation-phosphorylation conversion inhibits gastric cancer progression. J. Gastroenterol. 61, 369-385.
    Barylko, B., Taylor, C.A., Wang, J., Earnest, S., Stippec, S., Binns, D.D., Brautigam, C.A., Jameson, D.M., DeMartino, G.N., Cobb, M.H., et al., 2024. Mimicking protein kinase C phosphorylation inhibits Arc/Arg3.1 palmitoylation and its interaction with nucleic acids. Int. J. Mol. Sci. 25, 780.
    Blaustein, M., Piegari, E., Martinez Calejman, C., Vila, A., Amante, A., Manese, M.V., Zeida, A., Abrami, L., Veggetti, M., Guertin, D.A., et al., 2021. Akt Is S-palmitoylated: a new layer of regulation for Akt. Front. Cell. Dev. Biol. 9, 626404.
    Brigidi, G.S., Santyr, B., Shimell, J., Jovellar, B., Bamji, S.X., 2015. Activity-regulated trafficking of the palmitoyl-acyl transferase DHHC5. Nat. Commun. 6, 8200.
    Bu, N., Du, Q., Xiao, T., Jiang, Z.H., Lin, J.H., Chen, W.Y., Fan, B.W., Wang, J.Y., Xia, H.B., Cheng, C., et al., 2025. Mechanism of S-palmitoylation in polystyrene nanoplastics-induced macrophage cuproptosis contributing to emphysema through alveolar epithelial cell pyroptosis. ACS Nano 19, 18708-18728.
    Chang, Y.L., Zhu, J.L., Li, X.P., Deng, Y., Lai, B.R., Ma, Y.D., Tong, J., Liu, H.C., Li, J.J., Yang, C.Y., et al., 2024. Palmitoylation regulates myelination by modulating the ZDHHC3-Cadm4 axis in the central nervous system. Signal Transduction Targeted Ther. 9, 254.
    Charych, E.I., Jiang, L.X., Lo, F., Sullivan, K., Brandon, N.J., 2010. Interplay of palmitoylation and phosphorylation in the trafficking and localization of phosphodiesterase 10A: implications for the treatment of schizophrenia. J. Neurosci. 30, 9027-9037.
    Chen, Q.T., Zhang, Z.Y., Huang, Q.L., Chen, H.Z., Hong, W.B., Lin, T.W., Zhao, W.X., Wang, X.M., Ju, C.y., Wu, L.z., et al., 2022. HK1 from hepatic stellate cell-derived extracellular vesicles promotes progression of hepatocellular carcinoma. Nat. Metab. 4, 1306-1321.
    Chen, S.S., Shen, H.Y., Zhang, H.Y., Wang, Q., Ding, Y., Pu, X.X., Yang, C., Pang, R.X., Yang, Z., 2026. ZDHHC4-mediated ZEB-2 S-palmitoylation promotes melanoma epithelial-mesenchymal transition via deubiquitinating and stabilizing ZEB-2. Cell. Mol. Life Sci. 83, 87.
    Chen, S.Y., Zhu, B., Yin, C.Q., Liu, W., Han, C.P., Chen, B.E., Liu, T.Z., Li, X., Chen, X., Li, C.Y., et al., 2017. Palmitoylation-dependent activation of MC1R prevents melanomagenesis. Nature 549, 399-403.
    Chen, T., Zhang, H.L., Lv, S.T., Xu, Y., Ren, W., Wei, Y.F., Zhang, T.Y., Ge, Y.R., Lv, Y., Li, R.Y., et al., 2025. Amelioration of intervertebral disc degeneration using engineered extracellular vesicle-delivered ZDHHC5 via inhibiting PANoptosis. J. Tissue Eng. 16, 20417314251351011.
    Chen, X.R., Ma, H.H., Wang, Z., Zhang, S.R., Yang, H.R., Fang, Z.Y., 2017. EZH2 palmitoylation mediated by ZDHHC5 in p53-mutant glioma drives malignant development and progression. Cancer Res. 77, 4998-5010.
    Chen, X.Y., Ke, Z.H., Wei, S.H., Chen, J.J., Zhu, K., Xu, J.Q., Zhao, Y., Cen, M.Y., Jin, Y., Pan, Z.L., et al., 2026. ASCT2 palmitoylation regulated by JNK1-ZDHHC14 axis orchestrates glutamine metabolism and NSCLC progression. Cell Discov. 12, 13.
    Cherukuri, A., Carter, R.H., Brooks, S., Bornmann, W., Finn, R., Dowd, C.S., Pierce, S.K., 2004. B cell signaling is regulated by induced palmitoylation of CD81. J. Biol. Chem. 279, 31973-31982.
    Copits, B.A., Swanson, G.T., 2013. Kainate receptor post-translational modifications differentially regulate association with 4.1N to control activity-dependent receptor endocytosis. J. Biol. Chem. 288, 8952-8965.
    Ettelaie, C., Featherby, S., Rondon, A.M.R., Greenman, J., Versteeg, H.H., Maraveyas, A., 2021. De-palmitoylation of tissue factor regulates its activity, phosphorylation and cellular functions. Cancers (Basel) 13, 3837.
    Fairbank, M., Huang, K., El-Husseini, A., Nabi, I.R., 2012. RING finger palmitoylation of the endoplasmic reticulum Gp78 E3 ubiquitin ligase. FEBS Lett. 586, 2488-2493.
    Fan, Y.Z., Gao, Y., Nie, L., Hou, T., Dan, W.C., Wang, Z.X., Liu, T.J., Wei, Y., Wang, Y.Z., Liu, B., et al., 2023. Targeting LYPLAL1-mediated cGAS depalmitoylation enhances the response to anti-tumor immunotherapy. Mol. Cell 83, 3520-3532.
    Fu, H., Han, X., Guo, W.Q., Zhao, X.N., Yu, C.X., Zhao, W., Feng, S.S., Wang, J., Zhang, Z.S., Lei, K.J., et al., 2024. Cystathionine-γ-lyase contributes to tamoxifen resistance, and the compound I194496 alleviates this effect by inhibiting the PPARγ/ACSL1/STAT3 signalling pathway in oestrogen receptor-positive breast cancer. Sci. Rep. 14, 22988.
    Gauthier-Kemper, A., Igaev, M., Sundermann, F., Janning, D., Bruhmann, J., Moschner, K., Reyher, H.J., Junge, W., Glebov, K., Walter, J., et al., 2014. Interplay between phosphorylation and palmitoylation mediates plasma membrane targeting and sorting of GAP43. Mol. Biol. Cell 25, 3284-3299.
    Gu, M.R., Jiang, H.L., Tan, M.Z., Yu, L., Xu, N., Li, Y., Wu, H., Hou, Q., Dai, C.S., 2023. Palmitoyltransferase DHHC9 and acyl protein thioesterase APT1 modulate renal fibrosis through regulating β-catenin palmitoylation. Nat. Commun. 14, 6682.
    Guo, F.J., Luo, Y., Jiang, X.Y., Lu, X.Q., Roberti, D., Lossos, C., Kunkalla, K., Magistri, M., Rui, L.X., Verdun, R., et al., 2020. Recent BCR stimulation induces a negative autoregulatory loop via FBXO10 mediated degradation of HGAL. Leukemia 34, 553-566.
    Guo, H., Lin, Z., Zhang, D., Qin, Q., Li, Z., Yin, Y., Chen, J., Guo, W., 2025. ZDHHC9-mediated CD38 palmitoylation stabilizes CD38 expression and promotes pancreatic cancer growth. Commun. Biol. 8, 477.
    Harris, M., El Hindy, M., Usmari-Moraes, M., Hudd, F., Shafei, M., Dong, M., Hezwani, M., Clark, P., House, M., Forshaw, T., et al., 2020. BCAT-induced autophagy regulates Aβ load through an interdependence of redox state and PKC phosphorylation-implications in Alzheimer's disease. Free Radic. Biol. Med. 152, 755-766.
    Hawtin, S.R., Tobin, A.B., Patel, S., Wheatley, M., 2001. Palmitoylation of the vasopressin V1a receptor reveals different conformational requirements for signaling, agonist-induced receptor phosphorylation, and sequestration. J. Biol. Chem. 276, 38139-38146.
    Itoh, M., Yamashita, M., Kaneko, M., Okuno, H., Abe, M., Yamazaki, M., Natsume, R., Yamada, D., Kaizuka, T., Suwa, R., et al., 2018. Deficiency of AMPAR-palmitoylation aggravates seizure susceptibility. J. Neurosci. 38, 10220-10235.
    Jeffries, O., Tian, L., McClafferty, H., Shipston, M.J., 2012. An electrostatic switch controls palmitoylation of the large conductance voltage- and calcium-activated potassium (BK) channel. J. Biol. Chem. 287, 1468-1477.
    Jeong, D.W., Park, J.W., Kim, K.S., Kim, J., Huh, J., Seo, J., Kim, Y.L., Cho, J.-Y., Lee, K.-W., Fukuda, J., et al., 2023. Palmitoylation-driven PHF2 ubiquitination remodels lipid metabolism through the SREBP1c axis in hepatocellular carcinoma. Nat. Commun. 14, 6370.
    Jiang, L., Bin, Y., Huang, Y.Y., Wu, L.H., Qiu, X.Y., Du, Y.C., Mi, J.L., Liu, K., Deng, Y.Y., Ning, J.C., et al., 2026. Palmitoylation modification of SPI1 promotes nasopharyngeal carcinoma radioresistance through inhibiting c-CBL-mediated ubiquitination and degradation. Drug Resist. Update. 86, 101374.
    Komaniecki, G., Camarena, M.D.C., Gelsleichter, E., Mendoza, R., Subler, M., Windle, J.J., Dozmorov, M.G., Lai, Z., Sarkar, D., Lin, H.N., 2022. Astrocyte elevated gene-1 Cys75 S-palmitoylation by ZDHHC6 regulates its biological activity. Biochemistry 62, 543-553.
    Lai, B.R., Xu, C., Lai, S.Y., Zhou, M., Kong, H.S., Kong, E.Y., Yahaya, B.H., 2026. From EGFR PTM network to TKI resistance: spatial subtypes and targeting in lung cancer. Cancer Drug Resist. 9, 7.
    Li, M., Yu, X.X., Liu, Y.J., Ouyang, S.Q., Wu, L., Chen, X.H., Yu, H.Q., Chen, H.M., Lian, S.M., Li, Z.W., et al., 2025. KRAS/ABHD17C/ALOX15B axis promotes pancreatic cancer progression via ferroptosis evasion. Adv. Sci. 12, e04470.
    Li, T.Z., Bai, C.Y., Wu, B., Zhang, C.Y., Siriguleng, Wang, W.T., Shi, T.W., Zhou, J., 2023. The Elk-3 target Abhd10 ameliorates hepatotoxic injury and fibrosis in alcoholic liver disease. Commun. Biol. 6, 682.
    Li, W., Wang, Q.X., Qi, X.Y., Lu, H.M., Chen, Y.H., Shi, J.L., Wang, F., Wang, Z.Y., Lu, Y., Lu, Z.M., et al., 2020. An oncogenic viral interferon regulatory factor upregulates CUB domain-containing protein 1 to promote angiogenesis by hijacking transcription factor lymphoid enhancer-binding factor 1 and metastasis suppressor CD82. Cell Death Differ. 27, 3289-3306.
    Li, Z., Huang, Z., Liao, X., Li, H., 2025. Columbianadin targets TRIM7 to maintain P2X7 palmitoylation, inhibiting cuproptosis in synovial M2 macrophages. Phytomedicine 146, 157091.
    Liang, D., Jiang, L., Bhat, S.A., Missiroli, S., Perrone, M., Lauriola, A., Adhikari, R., Gudur, A., Vasi, Z., Ahearn, I., et al., 2023. Palmitoylation and PDE6δ regulate membrane-compartment-specific substrate ubiquitylation and degradation. Cell Rep. 42, 111999.
    Lievens, P.M.-J., Kuznetsova, T., Kochlamazashvili, G., Cesca, F., Gorinski, N., Galil, D.A., Cherkas, V., Ronkina, N., Lafera, J., Gaestel, M., et al., 2023. ZDHHC3 tyrosine phosphorylation regulates neural cell adhesion molecule palmitoylation. Mol. Cell. Biol. 36, 2208-2225.
    Lin, D.T., Makino, Y., Sharma, K., Hayashi, T., Neve, R., Takamiya, K., Huganir, R.L., 2009. Regulation of AMPA receptor extrasynaptic insertion by 4.1N, phosphorylation and palmitoylation. Nat. Neurosci. 12, 879-887.
    Liu, J., Shen, Y.Y., Liu, J., Xu, D.D., Chang, C.Y., Wang, J.M., Zhou, J., Haffty, B.G., Zhang, L.J., Bargonetti, J., et al., 2025. Lipogenic enzyme FASN promotes mutant p53 accumulation and gain-of-function through palmitoylation. Nat. Commun. 16, 1762.
    Liu, S.F., Zhang, N., Ji, X., Yang, S.Y., Zhao, Z., Li, P., 2025. Helicobacter pylori CagA promotes gastric cancer immune escape by upregulating SQLE. Cell Death Dis. 16, 17.
    Liu, X.F., Yu, J.T., Chen, Y.J., Liu, H.R., Liu, N., Peng, Q.S., 2026. Brucella abortus infection exploits ZDHHC3-mediated STAT3 palmitoylation to regulate host responses and promote persistence. Vet. Res. 57, 2.
    Liu, Z., Wang, H., Han, Y.M., Chen, Y., Wang, Y.Y., Zhang, S.Y., Mo, Y.Q., Wang, C.J., Xiao, M.M., Xu, B., 2025. ZDHHC20-mediated S-palmitoylation of KAP1/TRIM28 promotes DNA damage repair. Oncogene 44, 4533-4548.
    Lu, B., Sun, Y.Y., Chen, B.Y., Yang, B., He, Q.J., Li, J., Cao, J., 2024. zDHHC20-driven S-palmitoylation of CD80 is required for its costimulatory function. Acta Pharmacol. Sin. 45, 1214-1223.
    Lu, X.Q., Sicard, R., Jiang, X.Y., Stockus, J.N., McNamara, G., Abdulreda, M., Moy, V.T., Landgraf, R., Lossos, I.S., 2015. HGAL localization to cell membrane regulates B-cell receptor signaling. Blood 125, 649-657.
    Ma, X.C., Xia, Q.Q., Liu, K., Wu, Z.C., Li, C.X., Xiao, C.G., Dong, N.H., Hameed, M., Anwar, M.N., Li, Z.J., et al., 2023. Palmitoylation at residue C221 of Japanese encephalitis virus NS2A protein contributes to viral replication efficiency and virulence. J. Virol. 97, e0038223.
    Mo, Y.Q., Han, Y.M., Chen, Y., Fu, C.L., Li, Q., Liu, Z., Xiao, M.M., Xu, B., 2024. ZDHHC20 mediated S-palmitoylation of fatty acid synthase (FASN) promotes hepatocarcinogenesis. Mol. Cancer 23, 274.
    Modica, G., Tejeda-Valencia, L., Sauvageau, E., Yasa, S., Maes, J., Skorobogata, O., Lefrancois, S., 2025. Phosphorylation on serine 72 modulates Rab7A palmitoylation and retromer recruitment. J. Cell Sci. 138, jcs262177.
    Moritz, A.E., Rastedt, D.E., Stanislowski, D.J., Shetty, M., Smith, M.A., Vaughan, R.A., Foster, J.D., 2015. Reciprocal phosphorylation and palmitoylation control dopamine transporter kinetics. J. Biol. Chem. 290, 29095-29105.
    Nakao, F., Kobayashi, S., Mogami, K., Mizukami, Y., Shirao, S., Miwa, S., Todoroki-Ikeda, N., Ito, M., Matsuzaki, M., 2002. Involvement of Src family protein tyrosine kinases in Ca(2+) sensitization of coronary artery contraction mediated by a sphingosylphosphorylcholine-Rho-kinase pathway. Circ. Res. 91, 953-960.
    Nie, L., Fei, C.J., Fan, Y.Z., Dang, F.B., Zhao, Z.Y., Zhu, T.F., Wu, X.Y., Dai, T., Balasubramanian, A., Pan, J., et al., 2024. Consecutive palmitoylation and phosphorylation orchestrates NLRP3 membrane trafficking and inflammasome activation. Mol. Cell 84, 3336-3353.e3337.
    Niki, Y., Adachi, N., Fukata, M., Fukata, Y., Oku, S., Makino-Okamura, C., Takeuchi, S., Wakamatsu, K., Ito, S., Declercq, L., et al., 2023. S-palmitoylation of tyrosinase at cysteine500 regulates melanogenesis. J. Invest. Dermatol. 143, 317-327.e316.
    Peng, F., Lu, J.X., Su, K.Y., Liu, X.Y., Luo, H.D., He, B., Wang, C.X., Zhang, X.Y., An, F., Lv, D.K., et al., 2024. Oncogenic fatty acid oxidation senses circadian disruption in sleep-deficiency-enhanced tumorigenesis. Cell Metab. 36, 1598-1618.e1511.
    Qian, Z.W., Jiang, Y., Cai, Y., Gao, E.L., Wang, C.Z., Dong, J.F., Wang, F.X., Liu, L., Wu, D.P., Zhang, F., et al., 2025. FASN inhibits ferroptosis in breast cancer via USP5 palmitoylation-dependent regulation of GPX4 deubiquitination. J. Exp. Clin. Cancer Res. 44, 289.
    Santonico, E., Belleudi, F., Panni, S., Torrisi, M.R., Cesareni, G., Castagnoli, L., 2010. Multiple modification and protein interaction signals drive the Ring finger protein 11 (RNF11) E3 ligase to the endosomal compartment. Oncogene 29, 5604-5618.
    Sauvat, A., Ciccosanti, F., Colavita, F., Di Rienzo, M., Castilletti, C., Capobianchi, M.R., Kepp, O., Zitvogel, L., Fimia, G.M., Piacentini, M., et al., 2020. On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2. Cell Death Dis. 11, 656.
    Shao, S., Li, W., Hong, Y.L., Zeng, R.J., Zhu, L., Yi, L., Li, Y., Wang, Y.H., Huang, H.J., Jiang, X.W., et al., 2025. ZDHHC2-dependent palmitoylation dictates ferroptosis and castration sensitivity in prostate cancer via controlling ACSL4 degradation and lipid peroxidation. Adv. Sci. 23, e14077.
    Sharma, C., Rabinovitz, I., Hemler, M.E., 2012. Palmitoylation by DHHC3 is critical for the function, expression, and stability of integrin alpha6beta4. Cell. Mol. Life Sci. 69, 2233-2244.
    Shi, Y., Du, L.Y., Lv, D.D., Li, H., Shang, J., Lu, J.J., Zhou, L.Y., Bai, L., Tang, H., 2019. Exosomal interferon-induced transmembrane protein 2 transmitted to dendritic cells inhibits interferon alpha pathway activation and blocks anti-hepatitis B virus efficacy of exogenous interferon alpha. Hepatology 69, 2396-2413.
    Shipston, M., 2011. Ion channel regulation by protein palmitoylation. J. Biol. Chem. 286, 8709-8716.
    Sun, H., Cui, Z., Li, C., Gao, Z., Xu, J., Bian, Y., Gu, T., Zhang, J., Li, T., Zhou, Q., et al., 2024. USP5 promotes ripretinib resistance in gastrointestinal stromal tumors by MDH2 deubiquition. Advanced Science 11, e2401171.
    Takahashi, K., Niki, T., Ogawa, E., Fumika, K., Nishioka, Y., Sawa, M., Arai, H., Mukai, K., Taguchi, T., 2021. A cell-free assay implicates a role of sphingomyelin and cholesterol in STING phosphorylation. Sci. Rep. 11, 11996.
    Tan, X.H., Li, K.F., Yuan, Y.M., Xia, M.C., Zhao, F.Z., Ying, H.G., Zhou, Z., Gao, P.C., Xie, G.Q., Li, X.S., et al., 2026. Palmitoylation-mediated ubiquitination of SRPK1 regulates ferroptosis in high-fat-induced erectile dysfunction. Adv. Sci. 13, e13796.
    Tian, L.J., Jeffries, O., McClafferty, H., Molyvdas, A., Rowe, I.C.M., Saleem, F., Chen, L., Greaves, J., Chamberlain, L.H., Knaus, H.-G., et al., 2008. Palmitoylation gates phosphorylation-dependent regulation of BK potassium channels. Proc. Natl. Acad. Sci. U. S. A. 105, 21006-21011.
    Wang, K.F., He, W., Gong, Z., Gao, J., Gao, T.Y., Pan, N., Wu, D.Z., Yang, Y.J., Li, Z., Zhao, X., et al., 2025. ZDHHC11-mediated palmitoylation alleviates chondrocyte senescence and serves as a therapeutic target for osteoarthritis. Nat. Aging 5, 2228-2246.
    Wang, L.P., Wang, J.W., Ma, X.Q., Ju, G.M., Shi, C.F., Wang, W., Wu, J., 2023. USP35 promotes HCC development by stabilizing ABHD17C and activating the PI3K/AKT signaling pathway. Cell Death Discov. 9, 421.
    Wang, L.Q., Li, M.Q., Lian, G.Y., Yang, S., Cai, J., Cai, Z., Wu, Y.X., Cui, J., 2024. Palmitoylation acts as a checkpoint for MAVS aggregation to promote antiviral innate immune responses. J. Clin. Invest. 134, e177924.
    Wang, Y., Chen, Z.X., Li, R., Wei, D., Wang, S., Luo, H., Tu, Y.M., Liu, C., Xu, H.B., Xu, J.C., et al., 2025. S-palmitoylation of c-MET by CK2α-mediated zDHHC15 phosphorylation drives glioblastoma stem cell tumorigenicity. Neuro-Oncology 27, 1972-1986.
    Wang, Y., Ma, H.Y., Zhang, B.W., Li, S.N., Lu, B.J., Qi, Y.C., Liu, T.T., Wang, H., Kang, X.H., Liang, Y.M., et al., 2025. Protein palmitoylation in hepatic diseases: Functional insights and therapeutic strategies. J. Adv. Res. 76, 307-326.
    Wang, Y., Shen, N., Yang, Y., Xia, Y., Zhang, W.H., Lu, Y., Wang, Z.C., Yang, Z., Wang, Z.J., 2024. ZDHHC5-mediated S-palmitoylation of FAK promotes its membrane localization and epithelial-mesenchymal transition in glioma. Cell Commun. Signal. 22, 46.
    Wang, Z.J., Wang, Y., Shen, N., Liu, Y., Xu, X.Y., Zhu, R.Q., Jiang, H., Wu, X.T., Wei, Y.F., Tang, J.Y., 2024. AMPKα1-mediated ZDHHC8 phosphorylation promotes the palmitoylation of SLC7A11 to facilitate ferroptosis resistance in glioblastoma. Cancer Lett. 584, 216619.
    Wu, M.Y., Hu, L.Q., He, L.L., Yuan, L., Yang, L.L., Zhao, B., Zhang, L., He, X.J., 2024. The tumor suppressor NF2 modulates TEAD4 stability and activity in Hippo signaling via direct interaction. J. Biol. Chem. 300, 107212.
    Wu, M.Z., Zhou, X.J., Zhou, X.Y., Wang, G.X., Zeng, Y.Q., Li, J., Prochownik, E.V., Wang, F.B., Li, Y.J., 2024. ZDHHC3-mediated SCAP S-acylation promotes cholesterol biosynthesis and tumor immune escape in hepatocellular carcinoma. Cell Rep. 43, 114962.
    Xia, T.J., Cui, Y., Shi, H., Ma, Z.L., Gu, X.P., 2014. The effect of NR2B subunit palmitoylation at the spinal level after chronic dorsal root ganglia compression in rats. Anesth. Analg. 119, 1208-1214.
    Xiong, W.F., Sun, K.Y., Zhu, Y., Zhang, X.Q., Zhou, Y.H., Zou, X.P., 2021. Metformin alleviates inflammation through suppressing FASN-dependent palmitoylation of Akt. Cell Death Dis. 12, 934.
    Xu, J.N., Huo, L., Liu, J.T., Xu, W., Yu, T., 2026. Ketogenic diet can inhibit epileptic seizures by inhibiting RGMa methylation to promote GluA1 palmitoylation in the epileptic rat model. Nutr. Metab. (Lond.) 23, 30.
    Xu, M.H., Zheng, Y.M., Chen, J.B., Gao, C., Zhu, M., Ma, A.Y., Liang, B.G., Xu, W.X., Fan, J., Zhou, H.B., et al., 2025. CLDN4 palmitoylation promotes hepatic-to-biliary lineage transition and lenvatinib resistance in hepatocellular carcinoma. Cell Rep. Med. 6, 102208.
    Xu, M.X., Tan, J., Zhu, L.C., Ge, C.X., Zhang, Y., Gao, F.F., Dai, X.L., Kuang, Q., Chai, J., Zou, B.K., et al., 2023. Palmitoyltransferase ZDHHC3 aggravates nonalcoholic steatohepatitis by targeting S-palmitoylated IRHOM2. Adv. Sci. 10, e2302130.
    Yamanashi, Y., Kanai, M., 2026. Catalytic strategies for post-translational modifications regulating protein higher-order structure and properties. Chem. Soc. Rev. 55, 4409-4425.
    Yan, P.P., Liu, H.C., Zhou, T., Sun, P., Wang, Y.L., Wang, X.B., Zhang, L., Wang, T., Dong, J., Zhu, J., et al., 2022. Crosstalk of Synapsin1 palmitoylation and phosphorylation controls the dynamicity of synaptic vesicles in neurons. Cell Death Dis. 13, 786.
    Yang, J.-W., Larson, G., Konrad, L., Shetty, M., Holy, M., Jantsch, K., Kastein, M., Heo, S., Erdem, F.A., Lubec, G., et al., 2019. Dephosphorylation of human dopamine transporter at threonine 48 by protein phosphatase PP1/2A up-regulates transport velocity. J. Biol. Chem. 294, 3419-3431.
    Yao, H., Lan, J., Li, C.S., Shi, H.B., Brosseau, J.P., Wang, H.B., Lu, H.J., Fang, C.Y., Zhang, Y., Liang, L.X., et al., 2019. Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours. Nat Biomed Eng. 3, 306-317.
    Yin, H., Gui, Y., Du, G.W., Frohman, M.A., Zheng, X.L., 2010. Dependence of phospholipase D1 multi-monoubiquitination on its enzymatic activity and palmitoylation. J. Biol. Chem. 285, 13580-13588.
    Zhang, G.H., Jiang, P.S., Tang, W., Wang, Y.Y., Qiu, F.Q., An, J., Zheng, Y.P., Wu, D.D., Zhou, J.Y., Neculai, D., et al., 2023. CPT1A induction following epigenetic perturbation promotes MAVS palmitoylation and activation to potentiate antitumor immunity. Mol. Cell 83, 4370-4385.e4379.
    Zhang, M.M., Yu, T., Liu, Y.N., Lu, X., Chen, W.Z., Zhou, L.X., Xu, Y.J., Yang, M., Miller, A.D., Lin, H.N., 2025. SMAD2 S-palmitoylation promotes its linker region phosphorylation and TH 17 cell differentiation in a mouse model of multiple sclerosis. Sci. Signal. 18, eadr2008.
    Zhang, M.M., Zhou, L.X., Xu, Y.J., Yang, M., Xu, Y.L., Komaniecki, G.P., Kosciuk, T., Chen, X., Lu, X., Zou, X., et al., 2020. A STAT3 palmitoylation cycle promotes TH17 differentiation and colitis. Nature 586, 434-439.
    Zhang, N., Liu, J.P., Guo, R., Yan, L.J., Yang, Y.X., Shi, C., Zhang, M.M., Shan, B., Li, W.J., Gu, J.Y., et al., 2024. Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway. Mol. Cell 84, 4419-4435.
    Zhang, W.G., Trible, R.P., Samelson, L.E., 1998. LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity 9, 239-246.
    Zhang, Z.Y., Ren, C.Y., Xiao, R., Ma, S.Y., Liu, H.M., Dou, Y.T., Fan, Y.C., Wang, S., Zhan, P., Gao, C.J., et al., 2024. Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity. Sci. Immunol. 9, eadp7302.
    Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al., 2023. Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications. MedComm 4, e261.
    Zhou, B., Zhang, B., Qi, Y., Li, S., Liu, T., Li, T., Wang, Y., Wang, H., Lu, J., Cao, F., et al., 2026. Palmitoylation-dependent regulation of innate and adaptive immunity: molecular insights and translational opportunities. Cell. Mol. Biol. Lett. 31, 77.
    Zhou, B.H., Hao, Q.Y., Liang, Y.M., Kong, E.Y., 2022. Protein palmitoylation in cancer: molecular functions and therapeutic potential. Mol. Oncol. 17, 3-26.
    Zhou, B.H., Wang, Y., Zhang, L.C., Shi, X.Y., Kong, H.S., Zhang, M.J., Liu, Y., Shao, X., Liu, Z.L., Song, H.X., et al., 2022. The palmitoylation of AEG-1 dynamically modulates the progression of hepatocellular carcinoma. Theranostics 12, 6898-6914.
    Zhou, T.L., Li, J., Zhao, P.Q., Liu, H.J., Jia, D.Y., Jia, H., He, L., Cang, Y., Boast, S., Chen, Y.H., et al., 2015. Palmitoyl acyltransferase Aph2 in cardiac function and the development of cardiomyopathy. Proc. Natl. Acad. Sci. U. S. A. 112, 15666-15671.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (76) PDF downloads (0) Cited by ()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return